High Content Imaging Platform
The High Content Imaging (HCA/HCI) Platform is a high-throughput, multi-parameter cell analysis system designed for biopharmaceutical drug screening, cell phenotype analysis, and subcellular structure characterization. It integrates multi-channel fluorescence imaging, automatic cell segmentation, and quantitative analysis, enabling high-throughput detection of multiple cellular indicators in a single experiment. As an independent high-end cell analysis platform, it meets the high-throughput and multi-dimensional characterization needs of biopharmaceutical R&D.
High Content Imaging Platform
PharmaAnalytica has built a high-throughput, high-precision High Content Imaging Platform which supports high-efficiency, multi-parameter cell analysis, covering drug high-throughput screening, cell phenotype characterization, and subcellular localization research, providing powerful technical support for biopharmaceutical innovation and quality control.
NHQLive™ Label-free High-Content Live Cell Imaging Analyzer
An advanced label-free high-content live cell imaging analyzer integrated with quantitative phase imaging technology, bright-field and four fluorescence channels. It features high-resolution imaging of subcellular structures, long-term live cell monitoring with precise environmental control, and one-click AI intelligent analysis. Suitable for drug mechanism research, subcellular localization analysis, low-abundance target identification and drug-cell interaction analysis.
High Content Imaging System MCS21
A high-performance domestic high-content imaging system with bright-field, phase contrast and fluorescence imaging capabilities, equipped with red and green dual fluorescence channels. It supports automatic time-lapse live cell imaging and endpoint fixed cell analysis, integrated with AI intelligent analysis and remote monitoring functions. Widely used in pharmaceutical high-throughput screening, cell transfection monitoring, cell viability detection and multi-index cell phenotype analysis in biopharmaceutical R&D.
HF240 CO₂ Incubator
A high-stability CO₂ incubator with precise control of temperature, CO₂ concentration, and humidity, used to maintain the native state of live cells during long-term time-lapse imaging, avoiding cell damage and ensuring the reliability of experimental results.
HFsafe Biological Safety Cabinet
A Class II biological safety cabinet, providing a sterile operating environment for sample preparation, cell seeding, and drug addition, preventing cross-contamination of samples and ensuring the safety of operators and experimental samples.
Technical Advantages of the Platform
Core Pharmaceutical Testing Services
Drug High-Throughput Screening & Efficacy/Toxicity Evaluation
Main detection content: High-throughput screening of small molecules, antibodies, and peptides; quantitative evaluation of drug efficacy at the cellular level; assessment of drug-induced cytotoxicity to support lead compound screening and optimization.
Cell Phenotype & Intracellular Signal Pathway Analysis
Main detection content: Multi-index cell phenotype characterization, including cell viability, apoptosis, and cell cycle distribution; detection of intracellular signal pathway activation levels to analyze cellular response to drugs.
Drug Mechanism & Target Interaction Research
Main detection content: Subcellular localization of drugs and target proteins; co-localization analysis of drug-target complexes, providing visual and quantitative evidence for drug mechanism research.
Structure-Activity Relationship (SAR) Research
Main detection content: Analysis of the correlation between compound structure and biological activity, supporting the optimization of drug molecular structure.
Cell Therapy Product Characterization & Consistency Control
Main detection content: Phenotypic characterization of cell therapy products (e.g., CAR-T cells); evaluation of batch-to-batch consistency to ensure the stability and reliability of cell therapy products.
Biological Product Purity & Safety Detection
Main detection content: Detection of residual host cells in biological products; identification and quantification of impurities, ensuring the purity and safety of biological products meet regulatory standards.
PharmaAnalytica's High Content Imaging Platform provides high-throughput, multi-parameter, and high-precision cell analysis capabilities. With advanced instruments, automated workflows, and compliant data management, it serves as an independent high-end cell analysis tool to provide comprehensive, efficient, and reliable technical support for biopharmaceutical R&D, drug screening, and quality control.
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Need More Information or Request A Quotation?
Related Links
